← All stories
Markets
Does Hikma Pharmaceuticals (LSE:HIK) Face a Sharper Middle East Question Than Its Peers?
Highlights Hikma's regional manufacturing base gives it unusual sensitivity to Middle East developments Generics and injectables demand remains structurally steady regardless of headlines London trading stayed cautious as shipping-lane risk…
Covered by 1 outlet
All coverage · 1 article